You are here: Industry Insights > GSK

News List

GSK, Medicago launch late-stage trial of plant-derived COVID-19 vaccine pharmatimes
March 18, 2021
GlaxoSmithKline (GSK) and Canadian biopharma company Medicago have launched a Phase III trial of their adjuvanted plant-derived COVID-19 vaccine candidate.
GSK to leverage the Cell and Gene Therapy Catapult’s facility in Stevenage pharmatimes
March 12, 2021
GlaxoSmithKline (GSK) is set to leverage the Cell and Gene Therapy (CGT) Catapult’s facility in Stevenage to expand its own clinical trial manufacturing capacity for cell and gene therapy.
Hikma, GSK stop talks over potential buyout deal of Egypt, Tunisia assets expresspharma
March 12, 2021
Hikma Pharmaceuticals and GlaxoSmithKline have ended talks over a potential buyout deal for the latter’s pharma, consumer commercialisation and manufacturing business in Egypt and its drugs business in Tunisia, the companies said.
Vir, GSK to seek EUA for COVID-19 antibody therapy expresspharma
March 12, 2021
Vir and GSK also said that a new laboratory study showed the therapy, VIR-7831, was equally effective against the UK, South African and Brazilian variants of the coronavirus.
GSK Pharma rolls out multilingual peadiatric vaccine awareness campaign on Public app expresspharma
March 04, 2021
The ad campaign seeks to educate caregivers of children on the importance of timely vaccination and maintenance of records.
CHMP opinions: EMA refuses asthma label expansion for GSK’s COPD drug Trelegy Ellipta pharmaceutical-technology
March 02, 2021
The European Union’s healthcare regulator the European Medicines Agency (EMA) has decided against a label expansion for GlaxoSmithKline (GSK)’s drug Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) to include asthma.
GSK’s COVID-19 antibody shows potential in older patients pharmatimes
March 01, 2021
GlaxoSmithKline (GSK) has reported Phase II results for its investigational monoclonal antibody otilimab in hospitalised COVID-19 patients – and the data is mixed.
Sanofi and GSK start Phase II study of their COVID-19 vaccine candidate europeanpharmaceuticalreview
February 25, 2021
The dose finding study will assess the safety, reactogenicity and immunogenicity of the companies’ investigational COVID-19 vaccine in 720 participants.
GSK, Sanofi begin new COVID-19 vaccine study after setback expresspharma
February 23, 2021
The companies aim to reach final testing in the second quarter, and if the results are conclusive, hope to see the vaccine approved by the fourth quarter.
Sandoz to acquire GlaxoSmithKline’s cephalosporin antibiotics business pharmaceutical-business-review
February 20, 2021
Global leader in antibiotics and a division of Swiss multinational pharma company Novartis, Germany-based Sandoz has signed a contract to acquire GlaxoSmithKline’s (GSK) cephalosporin antibiotics.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page